The clinical and laboratory investigation of dysbetalipoproteinemia
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The clinical and laboratory investigation of dysbetalipoproteinemia
Authors
Keywords
-
Journal
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2020-04-07
DOI
10.1080/10408363.2020.1745142
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Type III Hyperlipoproteinemia: The Forgotten, Disregarded, Neglected, Overlooked, Ignored but Highly Atherogenic, and Highly Treatable Dyslipoproteinemia
- (2018) Allan D. Sniderman CLINICAL CHEMISTRY
- Evaluation of the Non-HDL Cholesterol to Apolipoprotein B Ratio as a Screening Test for Dysbetalipoproteinemia
- (2018) Christopher S. Boot et al. CLINICAL CHEMISTRY
- Autosomal dominant familial dysbetalipoproteinemia: A pathophysiological framework and practical approach to diagnosis and therapy
- (2017) Charlotte Koopal et al. Journal of Clinical Lipidology
- Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled crossover trial
- (2017) Charlotte Koopal et al. JOURNAL OF LIPID RESEARCH
- Familial dysbetalipoproteinemia
- (2017) Charlotte Koopal et al. Current Opinion in Endocrinology Diabetes and Obesity
- Pathognomonic Palmar Crease Xanthomas of Apolipoprotein E2 Homozygosity-Familial Dysbetalipoproteinemia
- (2016) Matan Rothschild et al. JAMA Dermatology
- Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis
- (2016) Simon B. Pedersen et al. JAMA Internal Medicine
- Vascular risk factors, vascular disease, lipids and lipid targets in patients with familial dysbetalipoproteinemia: A European cross-sectional study
- (2015) C. Koopal et al. ATHEROSCLEROSIS
- Dysbetalipoproteinaemia: A mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E
- (2014) A. D. Marais et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Prevalence of the Apolipoprotein E Arg145Cys Dyslipidemia At-Risk Polymorphism in African-Derived Populations
- (2013) Maen D. Abou Ziki et al. AMERICAN JOURNAL OF CARDIOLOGY
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
- (2011) et al. EUROPEAN HEART JOURNAL
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Non-HDL-cholesterol/apolipoprotein B ratio: A useful distinguishing feature in the screening for type III hyperlipoproteinemia
- (2010) Toshio Murase et al. Journal of Clinical Lipidology
- Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4
- (2010) Alexander M. Vezeridis et al. JOURNAL OF LIPID RESEARCH
- Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case–control study
- (2009) Paul N. Hopkins et al. ATHEROSCLEROSIS
- Rosuvastatin reduces non–high-density lipoprotein cholesterol and lipoprotein remnants in patients with dysbetalipoproteinemia (Fredrickson type III hyperlipoproteinemia)
- (2008) Dirk J. Blom et al. Journal of Clinical Lipidology
- A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias
- (2008) Jacqueline de Graaf et al. Nature clinical practice. Endocrinology & metabolism
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now